series-a
Stage
2016
Founded
4
Investors
About
Omeicos Therapeutics is a biopharmaceutical company developing first-in-class small molecule therapeutics. Their focus is on the prevention and treatment of cardiovascular diseases.
Explore Omeicos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.